Emerging studies highlights the power of metabolic peptides and hybrid agonists to revolutionize therapeutic approaches for systemic diseases. These advanced compounds offer the unique capacity to simultaneously activate multiple pathways, circumventing the challenges of traditional mono-therapy treatments. By fine-tuning metabolic signaling, they